14.3 Pain Management Infusions
Key Takeaways
- PCA (patient-controlled analgesia) uses a demand (bolus) dose, a lockout interval, and optional basal (continuous) rate—teach only the patient to press the button; family-administered PCA is a classic safety failure.
- IV opioid titration requires sedation and respiratory monitoring; naloxone reverses opioid-induced respiratory depression—use per protocol while supporting ventilation and reassessing frequently because naloxone may outlast or wear off before long-acting opioids.
- Epidural and intrathecal infusions deliver opioids and/or local anesthetics near the neuraxis—infusion nurses must protect the catheter, use preservative-free solutions as required, and recognize red-flag neurologic changes.
- Local anesthetic systemic toxicity (LAST) presents with neurologic and cardiovascular signs (tinnitus, metallic taste, seizures, arrhythmias, collapse)—stop the infusion, call for help, support ABCs; lipid emulsion therapy is a key rescue concept.
- Multimodal analgesia combines agents and routes to lower opioid burden; home elastomeric or electronic opioid pumps require clear education on rate, occlusion, residual volume, and when to seek help.
Pain infusions: control without complacency
Domain 3A Pain Management expects infusion nurses to deliver opioid and local-anesthetic therapies that relieve suffering while preventing respiratory arrest, neuraxial injury, and local anesthetic systemic toxicity. Technology (PCA pumps, epidurals, elastomeric balls) fails safely only when humans monitor sedation, respiration, and catheter integrity.
Quick Answer: PCA = demand dose + lockout ± basal; only the patient presses. Titrate IV opioids with sedation/respiratory checks; keep naloxone available. Epidural/intrathecal = neuraxial caution, preservative-free drugs, motor/sensory checks. LAST = stop local anesthetic, ABCs, lipid emulsion concept. Prefer multimodal plans. Home pumps (including elastomeric) need education on flow limits and emergency contacts.
Patient-controlled analgesia (PCA) principles
PCA lets the patient self-administer small IV opioid boluses within programmed safety limits.
Core program parameters
| Parameter | Meaning | Safety role |
|---|---|---|
| Demand (bolus) dose | Amount delivered each successful button press | Treats incident pain without large nurse boluses |
| Lockout interval | Minimum time between successful demand doses | Prevents stacking doses too quickly |
| Basal (continuous) rate | Optional ongoing mg/hr | Increases steady analgesia—and respiratory depression risk, especially in opioid-naïve patients |
| Hourly/4-hour limits | Cap on cumulative dose in some pumps | Secondary guardrail |
| Loading dose | One-time initial dose | Clinician-administered per order for uncontrolled pain |
Who presses the button?
Only the patient should activate PCA (except rare authorized nurse-controlled analgesia orders that are explicitly different). Family members pressing the button while the patient sleeps can cause fatal respiratory depression—this is a classic exam and Joint Commission-era safety theme.
Monitoring during PCA
- Sedation scale (e.g., Pasero-Opioid-Sedation or institutional tool)—increasing sedation precedes respiratory arrest more reliably than waiting for a low SpO2 alone
- Respiratory rate, depth, and SpO2; capnography when available/high risk
- Pain scores at rest and with activity
- Side effects: nausea, pruritus, urinary retention, constipation planning
- Pump history: frequent demands with little relief may mean inadequate dose, pump problems, or non-opioid pain generators—not automatic “more basal” without assessment
Exam trap: Adding basal rates casually to opioid-naïve patients “so they sleep through the night,” or teaching family to press for the patient.
IV opioid titration (nurse-administered)
When nurses titrate IV opioids (post-op, acute pain protocols, palliative pathways):
- Know the agent (morphine, hydromorphone, fentanyl concepts)—potency differs; do not mg-for-mg swap.
- Give ordered incremental doses; reassess pain and sedation/respiration at peak effect windows.
- Have oxygen and naloxone available in high-risk settings.
- Use extra caution with elders, OSA, concurrent benzodiazepines/sedatives, opioid-naïve status, and organ failure that prolongs drug effect.
- Document dose, time, response, and adverse effects.
Naloxone for opioid-induced respiratory depression
Naloxone is a competitive opioid antagonist.
- Indications teaching: significant respiratory depression, deep sedation with inadequate ventilation—not merely every complaint of sleepiness.
- Support airway and ventilation first principles while preparing naloxone.
- Give per protocol (often diluted incremental IV dosing in non-arrest situations to reverse respiration without full violent withdrawal when possible; emergent full doses in arrest pathways).
- Re-sedation risk: naloxone may wear off before long-acting or continuous opioids—monitor longer than a single vital-sign set; infusions or repeat doses may be needed.
- After reversal, investigate cause (PCA basal too high, family dosing, drug interactions) and notify provider; adjust the analgesic plan.
Epidural and intrathecal infusions—awareness for the infusion nurse
Neuraxial analgesia delivers opioids and/or local anesthetics into the epidural space or intrathecal (subarachnoid) space via specialized catheters managed with anesthesia/pain services.
High-level differences
| Route | Location concept | Implications |
|---|---|---|
| Epidural | Outside dura | Common continuous post-op infusions; combination local anesthetic + opioid frequent |
| Intrathecal | Into CSF | Much smaller doses; error amplification if epidural doses given intrathecally |
Nursing responsibilities (collaboration model)
- Verify preservative-free solutions when required; never inject vials with preservatives or the wrong concentration into neuraxial catheters.
- Maintain closed, labeled systems; yellow or specialized epidural tubing where used to avoid IV/epidural mix-ups.
- Assess sensory level, motor strength, and catheter site (leaking, disconnection, redness).
- Watch for red flags: progressive motor block beyond expectation, new severe back pain, bowel/bladder changes, headache after wet tap, signs of infection, respiratory depression from neuraxial opioids.
- Anticoagulation timing around catheter insertion/removal is a major safety domain—coordinate with providers; do not pull catheters on anticoagulant patients without clearance.
- If catheter dislodges or infusion disconnects, protect sterility, cover site, and notify anesthesia/pain service—do not reinsert.
Exam trap: Connecting an epidural catheter to a standard IV port or giving IV-intended bags neuraxially.
Local anesthetic systemic toxicity (LAST)
Local anesthetics (lidocaine, bupivacaine, ropivacaine, etc.) used in epidurals, nerve block infusions, or accidental IV administration can cause LAST.
Recognition (classic progression teaching)
Neurologic prodrome: tinnitus, perioral numbness, metallic taste, agitation, slurred speech, seizures, coma.
Cardiovascular: hypertension/tachycardia early possible → bradycardia, conduction block, ventricular arrhythmias, cardiovascular collapse (bupivacaine especially cardiotoxic in teaching).
Immediate response framework
- Stop the local anesthetic infusion/injection.
- Call for help / code team as needed; support ABCs; control seizures per protocol (benzodiazepines commonly first-line).
- Avoid certain drugs that worsen LAST in advanced algorithms—follow current ACLS-LAST guidance; the landmark rescue is IV lipid emulsion therapy concepts.
- Prepare for prolonged resuscitation; notify anesthesia/critical care early.
- For catheter systems, secure the site and preserve labeling for investigation.
Infusion nurses may not independently dose lipids daily, but CRNI expects recognition + stop + emergency activation + lipid emulsion awareness.
Multimodal analgesia
Multimodal pain management combines non-opioid analgesics (acetaminophen, NSAIDs when appropriate), regional techniques, adjuvants (e.g., gabapentinoids per order), nonpharmacologic methods, and the lowest effective opioid exposure.
Why infusion nurses care:
- Lower opioid rates → less PCA basal need and less respiratory risk.
- Scheduled non-opioids often matter more than PRN chaos.
- Advocate when pain is poorly controlled despite rising opioids—regional techniques or cause-specific treatment may be needed (e.g., ischemic pain, compartment syndrome—do not mask surgical emergencies with endless opioids alone).
Home opioid infusion pumps and elastomeric devices
Outpatient and hospice settings use electronic ambulatory pumps or elastomeric (“pain ball”) devices that deliver local anesthetic and/or opioid at approximate fixed rates.
Elastomeric concepts
- Flow rate depends on device design, temperature, fill volume, and tubing—teach patients not to heat the ball or alter tubing length casually.
- Occlusion, underdelivery, and early empty/late residual issues occur; patients need clear instructions for residual volume expectations.
- Site care for peripheral nerve catheter or central line continues at home—infection and disconnection teaching are essential.
Education essentials before discharge
| Topic | Teaching points |
|---|---|
| Goals | Comfort for function/sleep; not necessarily zero pain always |
| Pump alarms / clamp position | What to do and whom to call 24/7 |
| Over-sedation signs | When to stop/hold and seek emergency care |
| Naloxone availability | Many home opioid plans include take-home naloxone education |
| No unauthorized rate changes | Families must not “speed up” devices |
| Follow-up | Refill, removal, and catheter-pull appointments |
Integrated mini-scenarios
Scenario A — Family PCA: Spouse presses PCA button every lockout while patient is somnolent. Stop unauthorized dosing, assess respiration/sedation, notify provider, re-educate; consider naloxone if respiratory depression present.
Scenario B — Rising sedation: PCA basal running; RR 6, difficult to arouse. Stimulate, support airway, stop/hold opioid per protocol, give naloxone as ordered, continuous monitoring for re-sedation.
Scenario C — LAST prodrome: Patient with continuous peripheral nerve local anesthetic develops tinnitus, metallic taste, then agitation. Stop infusion, call emergency help, prepare for seizure control and lipid emulsion pathway.
Scenario D — Epidural tubing mix-up: IV antibiotic spiked toward epidural connector. Never connect; trace lines; use dedicated epidural systems and labels to prevent wrong-route disasters.
High-yield exam traps
- Allowing family-administered PCA
- Ignoring sedation trends while trusting SpO2 alone
- Forgetting naloxone re-sedation monitoring
- Neuraxial preservative or wrong-route errors
- Missing LAST early neurologic signs
- Treating multimodal therapy as “optional fluff” rather than opioid-sparing safety
- Home elastomeric misuse (heat, rate tampering, ignored occlusion)
- Pulling epidural catheters without checking anticoagulation timing
Which set correctly describes essential PCA programming and safety principles?
A patient on IV opioid PCA becomes difficult to arouse with a respiratory rate of 6/min. What is the priority framework?
Which cluster best suggests local anesthetic systemic toxicity (LAST) in a patient receiving a local anesthetic infusion?
For epidural or intrathecal infusions, which nursing principle is most critical?